TCTR20230915005CompletedPhase 2
Efficacy of Andrographis paniculata spray in acute pharyngitis: A randomized controlled trial
Abhaiphubet Chaopraya Hospital Foundation0 sites60 target enrollmentStarted: September 15, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to N/A (No limit) (—)
- Sex
- All
Inclusion Criteria
- •Adult patients (aged from 18 years old) presented in the hospital with an acute sore throat for less than 4 days were enrolled. The patients with a pain score greater than 5 out of 10 and a diagnosis of acute pharyngitis confirmed by an otolaryngologist were included in the study.
Exclusion Criteria
- •The exclusion criteria were positive COVID-19 test, history of allergy, intolerance, or sensitivity to any of the study medications, pregnant or lactating women, and patients who had taken antibiotics or corticosteroid less than 14 days prior.
Investigators
Similar Trials
Completed
Phase 3
The efficacy and safety of Andrographis paniculata extract for the treatment of acute nonspecific upper respiratory tract infections: a randomized double-blind placebo controlled trialAcute nonspecific upper respiratory tract infections with one or more symptoms such as fever,sore throat,nasal congestion,dry infrequent cough and had modified Centor Score of 2 or less.Andrographis paniculataandrographolideacute nonspecific upper respiratory tract infectionspharyngitiscommon coldTCTR20170329002Department of Thai Traditional and Alternative Medicine829
Completed
Phase 1
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trialTCTR20210708001Thai Traditional Medicine Knowlegde funding63
Recruiting
Phase 3
Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trialCOVID-19 patienrs, RT-PCR confirmedCovid-19 treatmentAndrographidis paniculatae extractPneumoniaTCTR20211224002Health System Research Institute736
Not yet recruiting
Phase 4
A clinical study to understand the combined effects of Andrographis & metformin, in comparison to metformin alone treatment on glycemic control in type 2 diabetes patientsCTRI/2019/11/021977Dr Anand Kumar Maurya
Completed
Phase 2
Efficacy of Andrographis paniculata extract Combined with Favipiravir Treatment to Prevent Disease Progression in mild to moderate COVID-19 Patients: A Double-blind, Randomized, Placebo-Controlled StudyMild to moderate COVID-19andrographolides, COVID-19, SARS-CoV-2, andrographis panniculata, favipiravirTCTR20210609001Chulabhorn Royal Academy146